fredag 16 maj 2014

The Diet and Cancer Connection



Written by Dr. Colin Champ

Maimonides, the famous astronomer, philosopher, scholar, and physician, remarked about the importance of diet in medicine nearly 900 years ago. As rates of diabetes, obesity, and cancer continue to rise, it would appear that his insightful message has fallen on deaf ears.



Read the artice here

The Diet and Cancer Connection

fredag 9 maj 2014

Ketonmätare


Om man inte är Diabetiket o inte har läkarintyg så kan man ändå beställa ketonmätare. Där finns i alla fall två ställen att beställa ketonmätare



Abbots "FreeStyle Precision" ketonmätare finns att beställa hos  apotea  


A. Menarini Diagnostics "GlucoMen LX Plus" ketonmätare finns att beställa hos Menarinidiagnostics

torsdag 8 maj 2014

The Truth about Saturated Fat, Pt 1 - Is the Government Out to Undermine Your Health? | The Dr. Oz Show

The Truth about Saturated Fat, Pt 1 - Is the Government Out to Undermine Your Health? | The Dr. Oz Show




The Truth about Saturated Fat, Pt 1

Saturated fat has maintained a bad reputation over the years. What if saturated fats could be a beneficial part of your diet? Dr. Oz and Dr. Peter Attia sit down to discuss groundbreaking new evidence.
Guests: Elizabeth Cohen, Dr. Peter Attia, Dr. Sue Varma


Find Your Personal Paleo Code, Pt 1 - Your Personal Paleo Code: The Diet to Lose Weight and Get Healthy for Life | The Dr. Oz Show

Find Your Personal Paleo Code, Pt 1 - Your Personal Paleo Code: The Diet to Lose Weight and Get Healthy for Life | The Dr. Oz Show




Find Your Personal Paleo Code, Pt 1

Learn how to lose weight and get healthy the caveman way! Dr. Oz has customized Paleo plans for your lifestyle, body type and genetic blueprint.
Guests: Nell Stephenson, Chris Kresser, Dr. Nina Radcliff, Dr. Holly Phillips

Do Carbs Cause Alzheimer's? Pt 1 - Do Carbs Cause Alzheimer's? | The Dr. Oz Show

Do Carbs Cause Alzheimer's? Pt 1 - Do Carbs Cause Alzheimer's? | The Dr. Oz Show




Do Carbs Cause Alzheimer's? Pt 1

Do you have the power to prevent Alzheimer's disease? Meet Dr. David Perlmutter, the controversial doctor who says you can control your genes by changing the way you eat. His message is simple: Cut carbs and load up on healthy fats!
Guests: Dr. David Perlmutter, Dr. Erin Gilbert

tisdag 6 maj 2014

carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet

http://informahealthcare.com/doi/full/10.3109/07853890.2014.894286
or
http://informahealthcare.com/doi/pdf/10.3109/07853890.2014.894286 



Background. 

Infl ammation may play an important role in type 2 diabetes. It has been proposed that dietary strategies can modulate infl ammatory activity. Methods. We investigated the eff ects of diet on infl ammation in type 2 diabetes by comparing a traditional low-fat diet (LFD) with a low-carbohydrate diet (LCD). Patients with type 2 diabetes were randomized to follow either LFD aiming for 55 – 60 energy per cent (E%) from carbohydrates ( n 30) or LCD aiming for 20 E% from carbohydrates ( n 29). Plasma was collected at baseline and after 6 months. C-reactive protein (CRP), interleukin-1 receptor antagonist (IL-1Ra), IL-6, tumour necrosis factor receptor (TNFR) 1 and TNFR2 were determined.

Results. 

Both LFD and LCD led to similar reductions in body weight, while benefi cial eff ects on glycaemic control were observed in the LCD group only. After 6 months, the levels of IL-1Ra and IL-6 were
signifi cantly lower in the LCD group than in the LFD group, 978 (664 – 1385) versus 1216 (974 – 1822) pg/mL and 2.15 (1.65 – 4.27) versus 3.39 (2.25 – 4.79) pg/mL, both P 0.05.

Conclusions

To conclude, advice to follow LCD or LFD had similar eff ects on weight reduction while eff ects on infl ammation diff ered. Only LCD was found signifi cantly to improve the
subclinical infl ammatory state in type 2 diabetes.
--------------------------------------------------------------------------------------------------

Key messages

• In type 2 diabetes, randomization to advice to follow a low-carbohydrate diet or a low-fat diet had
similar eff ects on weight reduction, while eff ects on infl ammation diff ered.
• Aft er 6 months, the low-carbohydrate diet, but not the low-fat diet, had a favourable impact on low-grade infl ammation in type 2 diabetes.







fredag 2 maj 2014

Anti-inflammatory properties of curcumin, a major constituent ofCurcumalonga: a review of preclinical and clinical research

Jurenka JS.

Journal

Altern Med Rev. 2009 Jun;14(2):141-53.

Affiliation

Erratum in

  • Altern Med Rev. 2009 Sep;14(3):277.

Abstract

Curcuma longa (turmeric) has a long history of use in Ayurvedic medicine as a treatment for inflammatory conditions. Turmeric constituents include the three curcuminoids: curcumin (diferuloylmethane; the primary constituent and the one responsible for its vibrant yellow color), demethoxycurcumin, and bisdemethoxycurcumin, as well as volatile oils (tumerone, atlantone, and zingiberone), sugars, proteins, and resins. While numerous pharmacological activities, including antioxidant and antimicrobial properties, have been attributed to curcumin, this article focuses on curcumin's anti-inflammatory properties and its use for inflammatory conditions. Curcumin's effect on cancer (from an anti-inflammatory perspective) will also be discussed; however, an exhaustive review of its many anticancer mechanisms is outside the scope of this article. Research has shown curcumin to be a highly pleiotropic molecule capable of interacting with numerous molecular targets involved in inflammation. Based on early cell culture and animal research, clinical trials indicate curcumin may have potential as a therapeutic agent in diseases such as inflammatory bowel disease, pancreatitis, arthritis, and chronic anterior uveitis, as well as certain types of cancer. Because of curcumin's rapid plasma clearance and conjugation, its therapeutic usefulness has been somewhat limited, leading researchers to investigate the benefits of complexing curcumin with other substances to increase systemic bioavailability. Numerous in-progress clinical trials should provide an even deeper understanding of the mechanisms and therapeutic potential of curcumin.
Free full text: Thorne Research, Inc.